Multiple-dose Proportionality Assessment
Multiple-Dose Proportionality Assessment is a pharmacokinetic evaluation method used to determine whether steady-state drug exposure increases in direct proportion to the administered dose across multiple dosing regimens, distinguishing it from single-dose assessments by focusing on cumulative exposure and time-dependent changes in drug disposition.
1
Publications
20
Citations
5
Authors
4
Institutions
Publications per year
2017–2026
0
Parents
1
Silke Appel‐Dingemanse, Yulia Hirschberg, Stuart Osborne et al. · European Journal of Clinical Pharmacology · 2001 · 20 citations
1–1 of 1
5
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 5
4
Tris Pharma (United States)
Monmouth Junction, United States
1 h-index
2 publications
40 citations
Novartis (France)
Rueil-Malmaison, France
1 h-index
1 publications
20 citations
Novartis (Switzerland)
Basel, Switzerland
1 h-index
2 publications
40 citations
Novartis (United States)
New York, United States
1 h-index
2 publications
40 citations
1–4 of 4
1 publications · 20 citations
1
h-index
1–1